Enhanced expression of endogenous antioxidant enzymes like HO-1 is suggestive of ongoing oxidative stress and activation of antioxidant defense mechanism in MS and EAE lesions and functions as a protective mechanism against ROS-mediated cellular toxicity [31]. The gene discussed is HMOX1; the disease is myeloid sarcoma.